Medicine and Dentistry
Stereotactic Body Radiation Therapy
100%
Cholangiocarcinoma
100%
Quality of Life
18%
Neoplasm
16%
Breathing
16%
Fiducial Marker
16%
Overall Survival
14%
Gemcitabine
10%
Cisplatin
10%
Progression Free Survival
10%
Radiation Therapy
10%
Electrocorticography
7%
Gastrointestinal Toxicity
7%
Cholangitis
7%
Disease Exacerbation
7%
Diseases
7%
Pharmacology, Toxicology and Pharmaceutical Science
Bile Duct Carcinoma
66%
Chemotherapy
33%
Overall Survival
25%
Neoplasm
16%
Cisplatin
16%
Progression Free Survival
16%
Gemcitabine
16%
Diseases
16%
Prospective Study
8%
Disease Exacerbation
8%
First-Line Chemotherapy
8%
Cholangitis
8%
Gastrointestinal Toxicity
8%